Global Infectious Disease POC Diagnostic Market Growth 2025-2031

The global Infectious Disease POC Diagnostic market size is predicted to grow from US$ 1766 million in 2025 to US$ 3247 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.

Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results、 Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Infectious Disease POC Diagnostic Industry Forecast” looks at past sales and reviews total world Infectious Disease POC Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease POC Diagnostic sales for 2025 through 2031. With Infectious Disease POC Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease POC Diagnostic industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease POC Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease POC Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease POC Diagnostic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease POC Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease POC Diagnostic.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease POC Diagnostic market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others

Segmentation by Application:
Hospital Bedside
Urgent Care and Retail Clinics
Home and Self-Testing
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
bioMérieux
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Infectious Disease POC Diagnostic market?

What factors are driving Infectious Disease POC Diagnostic market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Infectious Disease POC Diagnostic market opportunities vary by end market size?

How does Infectious Disease POC Diagnostic break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.